Navigation Links
2012 American Business Awards?Honors SynCardia with Two Gold Stevie® Awards
Date:6/20/2012

Tucson, AZ (PRWEB) June 20, 2012

On June 18, SynCardia Systems, Inc., manufacturer of the world’s first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, was honored with two Gold Stevie® Awards at the 10th Annual American Business Awards. SynCardia won “Company of the Year – Health Products and Services” and “Most Innovative Company of the Year – up to 100 Employees.”

“We are honored to be recognized as an industry leader by the nation’s premier business awards program,” said Michael Garippa, SynCardia Chairman/CEO/President. “With donor hearts in short supply, the SynCardia temporary Total Artificial Heart powered by the Freedom® portable driver is rapidly becoming the new standard of care for end-stage biventricular (both ventricles) heart failure.”

On April 24, SynCardia completed the minimum enrollment required by its FDA-approved Investigational Device Exemption (IDE) clinical study of the Freedom portable driver, the world’s first wearable power supply for the Total Artificial Heart. Weighing 13.5 pounds, the Freedom portable driver is designed to allow stable Total Artificial Heart patients who meet discharge criteria to leave the hospital and resume their lives at home while they wait for a matching donor heart. The Freedom driver, which is also CE approved for use in Europe, has supported more than 85 patients worldwide, accounting for more than 30 patient years of support.

Nicknamed the Stevies for the Greek word for “crowned,” the trophies were presented to honorees during a gala banquet on Monday, June 18 at the Marriott Marquis Hotel in New York. More than 500 nominees and their guests attended. The presentations were broadcast live by the Business TalkRadio Network. More than 3,000 nominations from organizations of all sizes and in virtually every industry were submitted this year for consideration.

CAUTION – The Freedom® portable driver is an investigational device, limited by United States law to investigational use.

###

About the SynCardia temporary Total Artificial Heart
SynCardia Systems, Inc. (Tucson, AZ) is the privately-held manufacturer of the world’s first and only FDA, Health Canada and CE approved Total Artificial Heart. Originally used as a permanent replacement heart… read more

Read the full story at http://www.prweb.com/releases/2012/6/prweb9621781.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
2. ChemoCentryx Presents Positive Results for Novel CCR2 Inhibitor in Preclinical Models of Diabetic Nephropathy at the 44th Annual Meeting of the American Society of Nephrology
3. Synteract and MediciNova Partner in "Fight For Air Walk" to Support the American Lung Association in California
4. GenWay Biotech Launches New Cardiovascular Diagnostic Blood Test at American Heart Association Scientific Sessions 2011
5. American Botanical Council Publishes a History of Adulteration
6. Elsevier Collaborates with the American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.)
7. Stemline Therapeutics, Inc. Announces Two Poster Presentations of SL-401 Efficacy Data Against Lymphoid Cancers at the 53rd Annual Meeting of the American Society of Hematology (ASH)
8. Coronado Biosciences Announces Phase 1 Results of CNDO-109 in AML to be Presented at the American Society of Hematology
9. Sangamo BioSciences Announces Presentation of New Data from ZFP Therapeutic® Program in Hemophilia B at American Society for Hematology Meeting
10. Ambit and Astellas Announce Results From Multiple Quizartinib Presentations at the 53rd Annual Meeting of the American Hematology Society
11. Survey Reveals Paternity Questions Loom for More Than One in 10 Americans
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/15/2017)... ... May 15, 2017 , ... Continuing to build off ... has today launched its first-ever cross-medium campaign, #StandFirm, with high-visibility social and digital ... social media channels, emphasizing Algenist’s stance on individuality and disruption: , We ...
(Date:5/12/2017)... ARBOR, Mich. , May 12, 2017 ... selected to present at the 36th annual Michigan Growth ... Forum. GreenMark, a Delaware corporation ... be presenting to investors in attendance, including more than ... deliver health benefits to society through biobased targeting technologies. ...
(Date:5/11/2017)... BioLife Solutions , Inc. (NASDAQ: BLFS ), a ... and tissue hypothermic storage and cryopreservation freeze ... and financial results for the first quarter of 2017. ... high of $2.4 million in the first quarter of 2017, ... Revenue growth was driven by sales of CryoStor ® ...
(Date:5/11/2017)... Yorba Linda, Ca (PRWEB) , ... May 11, ... ... (hPSCs) and primary rodent neurons both are excellent resources for disease modeling and ... culture and further differentiated into mature neurons for various applications, however, these often ...
Breaking Biology Technology:
(Date:4/11/2017)... , April 11, 2017 No two ... researchers at the New York University Tandon School ... Engineering have found that partial similarities between prints ... used in mobile phones and other electronic devices ... The vulnerability lies in the fact that ...
(Date:4/5/2017)... 2017  The Allen Institute for Cell Science today ... one-of-a-kind portal and dynamic digital window into the human ... first application of deep learning to create predictive models ... and a growing suite of powerful tools. The Allen ... future publicly available resources created and shared by the ...
(Date:4/4/2017)... YORK , April 4, 2017   EyeLock ... today announced that the United States Patent and Trademark ... patent broadly covers the linking of an iris image ... same transaction) and represents the company,s 45 th ... latest patent is very timely given the multi-modal biometric ...
Breaking Biology News(10 mins):